Search
  • 網站搜尋
亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。
返回搜索結果

Inhibition of Retinoic Acid Production for HIV Vaccination


技術優勢

- A vaccine strategy that circumvents the problem of induction of HIV-1 virus infection targets by current HIV vaccine candidates.- In vivo blockade of ALDH1a2 not only augments anti-HIV vaginal mucosal immunity, the most critical defense layer, but also enhances anti-HIV systemic immune responses.- Silencing ALDH1a2 in human DCs inhibits the expression of ß7 on activated CD4+ T cells, demonstrating strong clinical relevance.


詳細技術說明

Publications:An effective vaccination approach augments anti-HIV systemic and vaginal immunity in mice with decreased HIV-1 susceptible a4ß7high CD4+ T cells. Zhu W, Shi G, Tang H, Lewis DE, Song XT. Curr HIV Res. 2013 Jan;11(1):56-66.


國家/地區

美國

欲了解更多信息,請點擊 這裡
Business of IP Asia Forum
桌面版